K. Mataczyna and J. Wielgórska-Leszczyńska, “Information on Intellectual Capital in the Financial Statements and Annual Activity Reports of Pharmaceutical Companies”, KREM, no. 3(987), pp. 107–125, Dec. 2020, doi: 10.15678/ZNUEK.2020.0987.0306.